Mentholatum Deep Heat Cream
Authorisation PA25197/001/001 · The Mentholatum Company (Ireland) Limited
- Licence holder
- The Mentholatum Company (Ireland) Limited (all products →)
- Active substances
- Methyl salicylate, Racementhol, Eucalyptus oil, Turpentine oil
- Dosage form
- Cream
- Route of administration
- Topical use
- ATC code
- M02AC
- First authorised
- 16/07/1990
- Prescription status
- Product not subject to medical prescription
- Supply
- Supply through non-pharmacy outlets and pharmacies
- Legal basis
- Not Currently Available
Methyl salicylate: supply and approvals
3 authorised products on the HPRA list contain Methyl salicylate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 21 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 21 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 21 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Racementhol: supply and approvals
1 authorised product on the HPRA list contains Racementhol. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 21 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 21 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 21 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Eucalyptus oil: supply and approvals
4 authorised products on the HPRA list contain Eucalyptus oil. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 21 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 21 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 21 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 36 years (since 16 July 1990). The HPRA list marks it as marketed in Ireland.
Other medicines with Methyl salicylate in Ireland
3 other products on the HPRA list contain Methyl salicylate, from 3 licence holders; 3 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Menthol & Wintergreen Cream | Ovelle Limited | National authorisation (PA) | Marketed |
| Mentholatum Deep Heat Spray, cutaneous spray solution | The Mentholatum Company (Ireland) Limited | National authorisation (PA) | Marketed |
| Olbas Oil | LanesHealth (Ireland) Limited | National authorisation (PA) | Marketed |
Other medicines with Racementhol in Ireland
No other product on the HPRA list contains Racementhol.
Other substances in ATC group M02AC
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 5 other active substances share the group M02AC with this product:
Oleoresin capsicum (1) · Levomenthol (1) · Ethyl salicylate (1) · Hydroxyethyl Salicylate (1) · Methyl nicotinate (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
The Mentholatum Company (Ireland) Limited holds 2 products on the HPRA list, with 7 different active substances; 2 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.